Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis and Inhibits Radiographic Progression: Efficacy and Safety Data from a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study
Author(s):
Mease, P.; McInnes, I.B.; Kirkham, B.; Kavanaugh, A.; Rahman, P.; Heijde, D. van der; Landewe, R.; Nash, P.; Pricop, L.; Yuan, J.C.; Richards, H.; Mpofu, S.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-10-31
Language
English
Is part of
Arthritis and Rheumatology (2014), Vol. 66, p. S423-S424
